chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received the Pfizer COVID 19 vaccine in her left deltoid IM on Sunday, April 25th around 10:00 in the morning. Within 15 minutes, she experienced pain in the right hand and discoloration of her right index finger and thumb with "pain" and numbness. She called the office on Monday, April 26th and reported these symptoms in a telemed visit and she was urged to go to the ER. She declined and presented to the office today.  Her right index finger at the DIP joint distally is dusky, blue to grey and mottled. Capillary refill time is 2-3 seconds vs. remaining fingers in her hand. Vascular arterial ultrasound has been ordered for her right arm. Go to ER if worsen or acute symptoms (SOB, CP, numbness/tingling R arm)
Flu like symptoms, shivers, headache, tiredness, aches especially legs, arm pain at shot sight, fever, weakness, dizziness for 5 days.
No adverse effects; Improperly stored (-8.89 Celsius degree for 1 hour) PROQUAD was administered to the patient; Information has been received from a medical assistant referring to a patient of unknown age and gender. Information about medical history and concurrent conditions were not provided.   On 02-APR-2019, the patient was administered improperly stored dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot number R020815, expiration date 16-JAN-2020; strength, dose and frequency were not reported) was subcutaneously for prophylaxis with properly stored sterile diluent (no lot information was provided). The administered dose experienced a temperature excursion of -8.89 degree Celsius for 1 hour which were detected by a data logger. No previous excursions were reported. No adverse effects was reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1904USA005133: US-009507513-1904USA005132: US-009507513-1904USA005130: US-009507513-1904USA005129: US-009507513-1904USA005131: US-009507513-1904USA005627: US-009507513-1904USA005628: US-009507513-1904USA005629: US-009507513-1904USA005630: US-009507513-1904USA005631:
This was my first Moderna shot.  I had a very sore left arm, and achy shoulders on both sides.  10 Days later I developed a red rash about 3 in. by 3 in., on the left arm around the injection spot.  It was really not itchy, but still sore and red.  It did fade away about a week later.
Pt tolerated 6 week shots well. Went home with mom. On 4/25/01 at 15:42, per mom, pt had non-stop crying since 4/23/01. No fever, but inconsolable. Can hear baby in the background, screaming and crying. MD suspects "pertussis" of DTAP. Resolved on 4/26/01, per mom.
A medical assistant reported that one day post vax pt developed hives and subsequently recovered. No further info was available at the date of this report.
cold chills; fever; feel like I have flu symptoms; arm sore; feeling achy; This is a spontaneous report from a contactable consumer or other non hcp.  A female patient of an un-Age: 71; Unit: Unknown received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on 24Mar2021 as dose 1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced feeling achy, arm sore on 24Mar2021, patient experienced cold chills on 25Mar2021 15:00, patient experienced fever, and feel like i have flu symptoms on 25Mar2021. Caller stated she was looking on the paperwork she received. She received the first dose of the Pfizer vaccine yesterday. his arm got sore last night and this morning for a while. she was feeling achy. Today at 3pm she had cold chills, some of the stuff there that's on the paperwork. Cold, achy joints. she started with a temperature at 99.3 then 100.3. The paperwork says if a fever goes over 100F or higher call Care/doctors. patient temperature is 100.3 it's already after 6pm here. she just wants to know it went over 100. she took Tylenol early this morning for his arm because it was sore and took ibuprofen. she feels like she have flu symptoms. Most people say it's the 2nd shot that they had reactions. she wasn't going to get the vaccine. Everything was so sketchy, one thing one day and something the next day.  she got covid in Oct, even though there was a lot of talk about not taking it. It's similar to how she was feeling now, but twice as worse. The patient underwent lab tests and procedures which included body temperature: 99.3 fahrenheit, body temperature: 100.3 fahrenheit, body temperature: goes over 100f fahrenheit on 25Mar2021. The outcome of events was unknown.   No follow-up attempts are possible. No information about lot/batch number cannot requested.
Flu-like symptoms: fever (101.7), generalized weakness, nausea, malaise
Syncope event after receiving Tdap. Client had momentary fainting spell. No obvious injury to head or body. Pt denies hitting head. Able to speak and move right after incident. C/o lightheadedness. Was assisted to clinic room for further eval. Neuro check & VS monitored. Clts BP remained low, so given liquids & rest until stable.
Headache, face and eyes swelling, sinus congestion , difficulty swallowing, voice change, nausea  and belching.  Benadryl 25mg chewable taken, benadryl 25mg tablet and tylenol 1000 mg taken.   Monitored then approx 1 hour later face and lip tingling, increase in headache left side of head tingling, face and eyes remained swollen.  Horse voice ,difficulty swallowing 50mg of benadryl taken.
I began to have a sore throat on June 26. I tested myself on June 28th and was positive. It was sneezing coughing, a sore throat and upper respiratory congestion like a bad cold. I called my nurse practitioner and was prescribed PAXLOVID. The symptoms continued but I was feeling better the next day. I continued to take it for 5 days and was asked to not take it with my other prescribed medication. I completed the medication on Monday July 4th, I am still tired and coughing at night. I am 90% improved.
Patient received shots on 3/1/13. (R) thigh, Varicella, HIB, and Hepatitis A. Noticed reaction, inflammation at injection sites on 3/9/13, area hard to the touch. Evaluated in clinic by provider on 3/11/13.
Lost sense of taste and smell; Lost sense of taste and smell; Diarrhea; Coughing; Coughing; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of ANOSMIA (Lost sense of taste and smell), AGEUSIA (Lost sense of taste and smell), DIARRHOEA (Diarrhea), COUGH (Coughing) and PYREXIA (Coughing) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), COUGH (Coughing), PYREXIA (Coughing) and FATIGUE (Fatigue). On 14-Mar-2021, the patient experienced ANOSMIA (Lost sense of taste and smell) and AGEUSIA (Lost sense of taste and smell). At the time of the report, ANOSMIA (Lost sense of taste and smell), AGEUSIA (Lost sense of taste and smell), DIARRHOEA (Diarrhea), COUGH (Coughing), PYREXIA (Coughing) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no treatment drugs included no concomitant drugs included   Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Significant Followup Appended
NO other issues or concerns noted.; Caller reported that she was given MMRII IM instead of SQ.; This spontaneous report was received from a pharmacist, reporting on herself, a female patient of unknown age. There was no information regarding the patient's medical history, concurrent conditions and concomitant medications provided.  On 09-SEP-2022, the patient was vaccinated with measles, mumps, and rubella (Wistar RA 27-3) virus vaccine, live (M-M-R II) injection, administered intramuscularly (strength, dose, dose number, anatomical location, lot # and expiration date were not reported) for prophylaxis (incorrect route of product administration). There were no other issues or concerns noted. No PQC.
suspected vaccination failure; didn't stop the outbreaks; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows The patient had reported for himself/herself.  The age at vaccination was not reported. The patient received Shingles vaccine and it did not stop the outbreaks. The follow-up would not possible as no contact details were available. This case was considered as suspected vaccination failure, since the details regarding the completion of the primary immunization, time to onset for event and laboratory confirmation of shingles were not provided.
Left shoulder injection site cellulitis pain 7/10. Decreased left arm range of motion. Left chest shoulder and back pain 7/10.
This spontaneous report was received from a medical assistant via a company representative, concerning a patient of an unknown age and gender. There were no concurrent conditions, medical history, drug reactions or allergies or concomitant medications reported. On an unspecified date, the patient was vaccinated with an oral solution of ROTATEQ (dose, frequency, strength, lot # and expiration date were not reported) for prevention of Rotavirus. On an unknown date, after receiving ROTATEQ, the patient experienced "cough." The patient sought medical attention by contacted the medical assistance, and at the time of the report, it was unknown the patient's current status. No product quality complaint (PQC) was involved. Additional information has been requested.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 03-FEB-2017 at 11:07, the patient was vaccinated with improperly stored varicella virus vaccine live (Oka/Merck)(VARIVAX) injection (lot # M035142) (expiration date, dose and route of administration were not reported). The vaccine underwent previous temperature excursions. The number of previous excursions, time frames and values of incorrect temperature were unknown. No adverse effects were reported. Digital data logger was used. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000437: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454: US-009507513-1704USA000455: US-009507513-1704USA000456: US-009507513-1704USA000457.
Patient discovered she was pregnant after receiving H1N1 LAIV in Dec 20009. No urine pregnancy test completed at time of vaccination. Infant was born in August of 2010 with CHD that has required surgeries to repair.
Patient was fussy starting Saturday, April 22, 2023, spitting up,  has diarrhea and is refusing to eat; patient was crying intermittently, fussy and stiffening at 4/23/2023 visit; patient has been afebrile.  Viewed the patient's diaper - there was urine in the front and red/pink in the back and the stool was positive for occult blood (POCT done in office 4/23/2023).  Patient was referred to emergency room - was  diagnosed with  intussusception; failed reduction by radiology, successfully reduced in OR.
Patient states she received the Johnson & Johnson COVID vaccine on April 3rd. Patient states on April 8th she went to her dentist for cleaning and do not expiring any gum bleeding at this time. Patient states 2 day ago (April 19th) her gums were bleeding so bad that she could not see her teeth and patient states she had a nose bleed as well. Patient also states she was experiencing headaches. Patient presented the the Emergency Department on April 21st . Patient was found to have thrombocytopenia (PLT = 2). Patient was admitted to Hospital on April 21st (as of April 23rd, patient is still admitted). Hematology was consulted for further management of thrombocytopenia. Patient received 2 platelet transfusions, IVIG  x 2 doses, and is receiving corticosteroids.
Numbness and tingling downward from left deltoid to left thumb.  Decreased strength sensation.  Sx last for a few seconds and occur several times per day, every day since receiving vaccine.
Shingrix one month too early; This case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 59-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included ZOSTER VACCINE RECOMBINANT, ADJUVANTED (NON-LIVE) (SHINGRIX).   On 7th October 2021, the patient received the 2nd dose of Shingrix. On 7th October 2021, unknown after receiving Shingrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.  Additional details were provided as follows: The reporter was the part of a team in a health care clinic. The patient received 1st dose of Shingrix in September 2021. The patient received 2nd dose of Shingrix 1 month after 1st Shingrix dose, which led to shortening of vaccination schedule. The reporter was calling to get data available for early dosing of the vaccine. Pharmacist was transferred to Medical Information for dosing recommendation and additional data. The reporter was not probed for additional information regarding the adverse event or the patient involved. The reporter did not have more data, stated the nurse who vaccinated the patient would call with further information. The reporter consented to follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021208835:Same reporter
Allergic reaction to Zoster Vaccine. Pt states the night of the vaccine, he began to experience pain to BUE, stiffness, arms locking up, SOB, and dizziness and it lasted for the next 2 days. States he contacted Triage RN on phone the next day to report it and was told to go to nearest ED, pt states he declined to go to ED due to feeling slightly better and having his wife with him to watch him. Pt states he will not be able to receive the second dose but states he feels great now. Pt denies, SOB, N/V/D, chest pain, pain to BUE, stiffness, dizziness, muscle cramps at this time.
I started having neck pains, body aches, right arm pain that felt like my arm was ripping and it was hard for me to hold things in my right hand.  Over the next few days the symptoms had  gotten worse until I had to go to the emergency room. I then was admitted to the hospital for 5 days and was assessed for a stroke/TIA. I had to get an EEG, labs every 12 hours, I had to be hooked up to a heart monitor, I have developed sleep apnea .  I am now on medication that I will have to take for the rest of my life. I am still in so much pain. I have chronic headaches, my right arm isn?t better, my back is in so much pain, I have a bulging disk between C5-C6.  I can barely put weight on my right foot. Everything was affected on my right side but I received the shot in my left arm.
Mouth blisters; Fever; Chills; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via an unspecified route of administration in the left arm on 23Feb2021 at 11.30 (age at vaccination 44-years old), as single dose for COVID-19 immunisation and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: UNKNOWN), via unknown route of administration in the left arm on 16Mar2021 at 11.30 (age at vaccination 44-years old), as single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medication included bupropion (MANUFACTURER UNKNOWN) and vitamins (MANUFACTURER UNKNOWN), both for an unknown indication from an unspecified date. The patient did not had allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient did not test for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. On an unknown date of 2021, the patient experienced fever, chills, fatigue and mouth blisters. The patient did not received treatment for the adverse events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of fever, chills, fatigue and mouth blisters were unknown at the time of this report.   No follow-up attempts are possible; information about lot number cannot be obtained.
This spontaneous report was received from a Nurse refers to a 12 month old male patient. On 17-NOV-2009, the patient was vaccinated with first dose of VARIVAX (Merck) (Expiry: 11-JUL-2010) (0.5 ml once) subcutaneous. On 17-NOV-2009 (also reported as within 24 hours) the patient experienced fever and chicken pox-like rash. On 24-APR-2014, the patient visited the physician office and reported the events. The outcome of fever and chicken pox-like rash was reported as recovered. The reporter did not provide the causality between the event and the suspect drug. Additional information has been requested.
heart is pounding; itching; rash a little bit in her neck, rash in back; gets up and feels like she will pass out; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart is pounding), PRURITUS (itching), RASH (rash a little bit in her neck, rash in back) and DIZZINESS (gets up and feels like she will pass out) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045J21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.    On 07-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In December 2021, the patient experienced PALPITATIONS (heart is pounding), PRURITUS (itching), RASH (rash a little bit in her neck, rash in back) and DIZZINESS (gets up and feels like she will pass out). At the time of the report, PALPITATIONS (heart is pounding) had not resolved, PRURITUS (itching) and DIZZINESS (gets up and feels like she will pass out) outcome was unknown and RASH (rash a little bit in her neck, rash in back) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication was reported. Patient took an unknown medication for rash and no treatment information was provided for other reported events.  Patient stated, after first dose she had symptoms, she thought they will go away but they was still here. Her heart was pounding, this was not normal. She never had a heart problem. She was due her second shot on 05-Jan-2022 but she did not know if she should get it. She also had a rash, a little bit in her neck and back. She put medication and it went away. Also had itching. She gets up and feels like she will pass out.
This initial report was received from a nurse practitioner concerning a 62 year old female patient. The patient's medical history included chronic maxillary sinusitis, unspecified mycosis, leukoplakia oral, anxiety, insomnia an elevated cholesterol. The patient did not have allergies. The patient's concomitant therapies included LIPITOR, AMBIEN, COMPAZINE and amitriptyline hydrochloride (manufacturer unknown). On 01-SEP-2016, the patient was vaccinated with ZOSTAVAX, subcutaneously for prevention of shingles (dose, strength, anatomical location and lot number were not provided). On the same date, the patient experienced tachycardia with a heart rate of 108 (unit not provided). No laboratory diagnostic studies were performed and the patient did not receive treatment for the event. At the reporting time, the outcome of tachycardia was unknown. The reporter did not assess the causal relationship between therapy with ZOSTAVAX and the reported event. Additional information has been requested.
Paresthesias and focal motor weakness of LUE. Evaluated by Neurology & ID - LP, MRI brain & neck done - all WNL per neurology. Some residual facial paresthesias as of 9/01/11 at time of reassessment.
pt had sz 4 days p/vax & shots taken to hosp-was told by ER md sz was related to fever; no problems now & had nl exam 17OCT94;
Redness more than 1-2 inches around the injection site on the arm; This is a spontaneous report from a contactable physician (pediatrician) via a Pfizer sales representative. This physician reported similar event for 4 patients. This is the fourth of 4 reports. A patient of unspecified age and gender received the first dose of meningococcal group b rlp2086 (TRUMENBA, lot number and expiration date were not reported), via an unspecified route of administration on an unspecified date on the patient's arm at single dose for routine vaccination. The patient's medical history and concomitant medications were not reported. It was reported on an unspecified date that the patient experienced redness more than 1-2 inches around the injection site on the arm. The outcome of the event was recovered on an unspecified date.   Information on the batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2019291868 Same reporter/drug/event, different patient
Patient has received various Covid-19 immunizations in different pharmacies: Janssen 8/25/2021, Moderna 3/16/2021, Moderna 4/13/21, Pfizer 11/17/21, Pfizer 2/23/22 and Pfizer 4/8/22.  It was discovered on database after registering a vaccine for the patient. Patient did not admit he received multiple Covid-19 vaccines. Patient states he feels great .